Other Events ·
Capricor Therapeutics, Inc. entered into a lease agreement for approximately 171,000 rentable square feet in San…
CAPRCapricor Therapeutics, Inc.
Capricor Therapeutics, Inc. entered into a lease agreement for approximately 171,000 rentable square feet in San Diego, California, to serve as its new headquarters and expanded manufacturing cleanrooms, R&D laboratory, and administrative offices. The lease term commences on the earlier of FDA approval of Deramiocel for Duchenne muscular dystrophy or December 31, 2026, with an initial monthly base rent of approximately $958,000, subject to a 3.0% annual increase. Capricor will receive an 18-month full rent abatement and a subsequent 06-month partial rent abatement. Capricor Therapeutics, Inc. is a biotechnology company focused on developing therapeutic solutions for neuromuscular and neuromuscular-related diseases.